by What is the Hospital Acquired Infection Control Market Size in 2026?
The global hospital acquired infection control market size was valued at USD 22.30 billion in 2025 and is projected to grow from USD 23.79 billion in 2026 to approximately USD 42.65 billion by 2035, registering a CAGR of 6.70% during the forecast period from 2026 to 2035. The market growth is driven by the increasing prevalence of hospital-acquired infections and the rising demand for advanced infection prevention and control solutions.
Key Takeaways
- North America dominated the global hospital acquired infection control market with a share of around 36% in 2025.
- Asia Pacific is expected to grow at the fastest CAGR of 7% during the forecast period.
- By component, the consumables segment held a dominant position in the market with a share of 50% in 2025.
- By component, the equipment segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
- By end-use, the hospitals & ICUs segment accounted for a revenue share of 60% in the market in 2025.
- By end-use, the ambulatory surgical centers segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
- By infection type, the surgical site infections segment led the global market with a share of 28.7% in 2025.
- By infection type, the urinary tract infections segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
- By technology, the sterilization technology segment registered its dominance over the global market with a share of 55% in 2025.
- By technology, the disinfection technology segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
- By distribution channel, the direct sales segment dominated the global market with a share of 60% in 2025.
- By distribution channel, the distributors segment is the second-largest shareholder and is expected to grow at a significant rate between 2026 and 2035.
Market Overview
The hospital acquired infection control market includes a wide range of products and services designed to prevent infections that patients may acquire during treatment in healthcare facilities. The market covers sterilization equipment, disinfectants, personal protective equipment (PPE), and advanced monitoring systems aimed at minimizing infection risks across hospitals, clinics, and other healthcare settings. These solutions play a crucial role in improving patient safety, enhancing clinical outcomes, and maintaining high healthcare standards worldwide. Market growth is primarily driven by the increasing prevalence of hospital-acquired infections (HAIs), rising awareness regarding infection prevention practices, and growing concerns over antimicrobial resistance.
Hospital Acquired Infection Control Market Trends
- Hospitals are increasingly adopting automated and smart sterilization technologies to enable real-time infection tracking, improve disinfection efficiency, and reduce the risk of human error in infection control practices.
- The growing demand for non-toxic and biodegradable disinfectants is influencing the market, as healthcare facilities increasingly prefer environmentally friendly solutions that minimize toxic residue and support sustainability goals.
- Rising concerns about antimicrobial resistance are encouraging innovation in infection prevention technologies, including antimicrobial coatings, UV-based disinfection systems, and advanced sterilization solutions aimed at improving patient outcomes.
- The increasing use of single-use and disposable medical products is transforming infection control practices by reducing the risk of cross-contamination through disposable gloves, gowns, and medical equipment, thereby enhancing hygiene and operational efficiency.
How is AI Impacting the Hospital Acquired Infection Control Market?
Artificial Intelligence (AI) is playing a significant role in transforming the hospital acquired infection control market. AI-powered systems can analyze large volumes of patient data, clinical records, and environmental information to identify infection risks at an early stage and support timely intervention. Machine learning algorithms help detect patterns associated with hospital-acquired infections, enabling healthcare professionals to predict potential outbreaks and optimize infection prevention strategies. In addition, AI-driven robotic disinfection technologies, including autonomous UV sterilization systems, are streamlining hospital operations by improving sterilization efficiency and reducing human exposure to infectious pathogens.
Market Dynamics
Drivers
Increasing Surgical Procedures Driving Demand for Infection Control Solutions
The rising number of surgical procedures worldwide is a key factor driving the growth of the hospital acquired infection control market. Increasing cases of lifestyle-related diseases, a growing aging population, and the higher incidence of spinal disorders and sports-related injuries are significantly boosting the demand for surgical interventions. With the continuous increase in surgical volumes, the demand for sterilization equipment, disinfectants, and advanced infection prevention solutions is also rising to enhance patient safety and minimize the risk of hospital-acquired infections.
Segment Insights
Component Insights
The Consumables Segment Held a 50% Market Share in 2025
The consumables segment dominated the hospital acquired infection control market, accounting for a 50% share in 2025. The segment’s growth is driven by the high and continuous demand for products such as disinfectants, sterilization wraps, gloves, masks, and wipes across healthcare facilities. Increasing emphasis on patient safety, stringent healthcare regulations, and rising awareness regarding infection prevention practices have further accelerated the demand for infection control consumables.
End-Use Insights
Hospital Acquired Infection Control Market Share, By End-Use, 2025-2035 (%)
The hospitals & ICUs segment dominated the hospital acquired infection control market with the largest share of 60% in 2025, driven by the high number of critically ill patients, frequent invasive procedures, and increased risk of infection transmission in these environments. These facilities require continuous sterilization, advanced disinfection systems, and strict hygiene protocols to prevent hospital-acquired infections. Rising pressure on healthcare systems to expand ICU capacity further increases the demand for infection control solutions.
Region Insights
North America Hospital Acquired Infection Control Market Size and Growth 2026 to 2035
The North America hospital acquired infection control market size was valued at USD 8.03 billion in 2025 and is expected to reach approximately USD 15.35 billion by 2035, growing at a CAGR of 6.69% from 2026 to 2035.
North America Lead the Hospital Acquired Infection Control Market in 2025
North America led the global hospital acquired infection control market with a share of 36% in 2025, due to the existence of advanced healthcare systems, high healthcare expenditure, and stringent regulatory frameworks focused on infection prevention and patient safety. The region also benefits from widespread adoption of advanced sterilization equipment, disinfectants, and computer-based infection surveillance systems in hospitals and intensive care units. In addition, rising hospital admissions, increasing surgical procedures, and a growing prevalence of chronic diseases are further driving demand for infection control solutions.
U.S. Hospital Acquired Infection Control Market Size and Growth 2026 to 2035
The U.S. hospital acquired infection control market size is calculated at USD 6.02 billion in 2025 and is expected to reach nearly USD 11.52 billion in 2035, accelerating at a strong CAGR of 6.71% between 2026 and 2035.
U.S. Market Trends
The U.S. is a major contributor to the hospital acquired infection control market in North America. This is mainly due to its well-established healthcare infrastructure, strong regulatory environment, and early adoption of advanced medical technologies. Hospital-acquired infections (HAIs) represent a significant burden in the country, prompting healthcare institutions to invest heavily in sterilization equipment, disinfectants, protective gear, and infection monitoring systems. Government initiatives aimed at reducing HAIs and improving healthcare quality standards are further supporting market growth.
Europe: The Second-Largest Shareholder in 2025
Europe held the second-largest market share of 25% in 2025 and is expected to grow at a notable CAGR during the projection period. The regional market growth is driven by strong emphasis on healthcare quality and safety, along with strict regulatory standards for infection control. The increasing incidence of hospital-acquired infections, rising healthcare costs associated with prolonged hospital stays, an aging population, and a higher number of surgical procedures are all contributing to increased demand for infection control solutions.
UK Market Trends
The UK leads the European market due to its well-developed healthcare system and strong focus on infection prevention. The National Health Service (NHS) continues to implement stricter hygiene protocols and promote the adoption of advanced sterilization and disinfection technologies. Rising HAI cases and increasing surgical volumes are further driving the demand for effective infection control solutions in the country.
Hospital Acquired Infection Control Market Companies
- 3M is a global leader in healthcare and infection prevention solutions, offering sterilization products, surgical supplies, and personal protective equipment.
The company focuses on improving patient safety and reducing healthcare-associated infections through advanced medical technologies. - STERIS provides infection prevention, sterilization, and surgical support products for hospitals and healthcare facilities worldwide.
Its solutions help healthcare providers maintain sterile environments and improve operational efficiency. - Ecolab specializes in cleaning, sanitation, and infection prevention services for healthcare and industrial sectors.
The company offers advanced disinfectants and hygiene solutions to support safer healthcare environments. - Getinge develops sterilization systems, surgical equipment, and infection control solutions for hospitals and laboratories.
The company focuses on enhancing healthcare efficiency and ensuring high standards of patient safety. - Cantel Medical provides infection prevention products and services for hospitals, dental clinics, and medical laboratories.
Its portfolio includes sterilization systems, disposable products, and water purification technologies. - Advanced Sterilization Products offers low-temperature sterilization and high-level disinfection technologies for healthcare facilities.
The company helps hospitals reduce infection risks and improve compliance with sterilization standards. - Sterigenics delivers contract sterilization and laboratory testing services for medical device manufacturers and healthcare companies.
Its advanced sterilization technologies help ensure product safety and regulatory compliance. - Belimed manufactures cleaning, disinfection, and sterilization systems for hospitals and pharmaceutical industries.
The company is known for providing efficient infection control solutions that support healthcare safety standards. - MMM Group develops sterilization, cleaning, and thermal disinfection equipment for healthcare and life science applications.
Its solutions are designed to improve hygiene management and infection prevention processes. - Midmark Corporation offers medical equipment and workflow solutions for hospitals, clinics, and healthcare practices.
The company supports infection control efforts through advanced sterilization and patient care technologies.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Get Sample : https://www.precedenceresearch.com/sample/8400
You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344
